|
|
USMLE Step1 Behavioral Science攻略法 |
ブログでもUSMLEに役立つ参考書を紹介しています。のぞいてみてください。
USMLEにも役立つ医学生やレジデントのための教科書・参考書ナビ、医学書ガイド
FIRST aid USMLE step1 USMLE 受験者必須のテキストです。
Behavioral Science攻略法とポイント
|
|
日本の医師国家試験では決して出題は多い分野ではないが、
USMLE Step1の頻出問題である。臨床医学のUSMLE Step2の分野ではPsychiatry（精神科）とPreventive Medicine（予防医学）に関連している。
Psychiatryは日本の教科書を参考にするならDSMに準拠した教科書が必要。
日本人が最も弱い分野であり、逆に言うと勉強することにより最も点数をあげることができる分野である。
Defence mechanismなどが出題される。
Preventive medicineやepidemiology関連ではsensitivity,specificity,positive predictive valueなどが出題される。
USMLE Step1を受けるのなら誰がなんと言ってもMUST BUYの2冊組み
■First Aid for the USMLE Step 1 誰もが持っているアンチョコ本
■Kaplan USMLE Step 1 Qbook 受験者のほとんどがこなす問題集
|
|
|
BRS Behavioral Science (Board Review Series)
|
BRS Behavioral ScienceはUSMLE受験者の間でも人気のシリーズです。
USMLE2020 Step1 Behavioral Science行動医学 サンプル問題
|
USMLE Step1のBehavioral Science行動医学関連ではどのような問題がでるのか？
以下の問題はUSMLE公式ページ（https://www.usmle.org/）で公開されている2020サンプル問題から2問引用した。
“No.9 After being severely beaten and sustaining a gunshot wound to the abdomen, a 42-year-old woman undergoes
resection of a perforated small bowel. During the operation, plastic reconstruction of facial fractures, and open
reduction and internal fixation of the left femur are also done. Thirty-six hours postoperatively, she is awake but not
completely alert. She is receiving intravenous morphine via a patient-controlled pump. She says that she needs the
morphine to treat her pain, but she is worried that she is becoming addicted. She has no history of substance use
disorder. She drinks one to two glasses of wine weekly. Which of the following initial actions by the physician is
most appropriate?
(A) Reassure the patient that her chance of becoming addicted to narcotics is minuscule
(B) Maintain the morphine, but periodically administer intravenous naloxone
(C) Switch the patient to oral acetaminophen as soon as she can take medication orally
(D) Switch the patient to intramuscular lorazepam
(E) Switch the patient to intravenous phenobarbital”
“No.12 Over 1 year, a study is conducted to assess the antileukemic activity of a new tyrosine kinase inhibitor in patients
with chronic myeloid leukemia in blast crisis. All patients enrolled in the study are informed that they would be
treated with the tyrosine kinase inhibitor. They are assigned to successive dose cohorts of 300 to 1000 mg/day of the
drug. Six to eight patients are assigned to each dose. Treatment efficacy is determined based on the results of
complete blood counts and bone marrow assessments conducted regularly throughout the study. This study is best
described as which of the following?
(A) Case-control study
(B) Crossover study
(C) Open-labeled clinical trial
(D) Randomized clinical trial
(E) Single-blind, randomized, controlled trial”
解説はこちらのUSMLE攻略ブログで
難しいと思う人は↓↓↓で勉強しよう。
村井 俊哉/林 晶子 丸善出版 2020年01月30日
|
|
|
